Arkolith/Insider Trading/SQZ/Form 4

Sharei Armon

President and CEO, DirectorSQZ Biotechnologies Co (SQZ) · full profile →Form 4 · filed Dec 22, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 22, 2021Option exercise(M)11K$1.81$20K271K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 22, 2021Option exercise(M)11K—$0185K

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-21-070962) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML